Nephrocare Health Services Limited
NEPHROPLUS · ISIN: INE428V01029
Nephrocare Health Services Limited is a small cap company in the Healthcare Services sector, listed on the NSE under ISIN INE428V01029.
Price and day-range figures above come from the latest NSE/BSE close, not a delayed quote. Where shown, RSI (14-day), SMA50/SMA200, and ADX measure momentum and trend from real daily closing prices - an RSI above 70 or below 30 typically signals overbought or oversold conditions, and a price above its SMA200 is a common long-term uptrend marker. ADTV (20-day average daily traded value) reflects real liquidity, not a projection. Fundamentals, when available, come from the company's own filed financials rather than a third-party estimate.
CHART
Nephrocare Health Services Limited - growth of ₹100
Growth of ₹100 invested on 2026-09-30, not raw price - the standard way to compare performance regardless of price level. Daily resolution for the last 90 days, weekly up to 2 years, monthly beyond that.
1M
-4.73%
3M
-7.79%
6M
+18.76%
1Y
-
3Y CAGR
-
5Y CAGR
-
Earnings (TTM)
LEARN: Revenue and PAT · EPS · P/E
Not available for this stock yet.
Technicals
As of 2026-10-29.
Shareholding Pattern
CHART
Shareholding by category
Corporate Actions
No corporate actions on record for this stock.
Recent Deals
| Date | Type | Quantity |
|---|---|---|
| 2026-09-24 | BULK | 8,15,776 |
| 2026-09-24 | BULK | 8,23,311 |
| 2026-09-24 | BULK | 25,45,719 |
| 2026-09-24 | BULK | 8,42,109 |
| 2026-09-02 | SHORT_SELL | 20 |
| 2026-08-13 | SHORT_SELL | 27 |
Frequently asked questions
What do Nephrocare Health Services Limited's technical indicators show?
As of 2026-10-29, Nephrocare Health Services Limited's RSI (14-day) is 44.35 - readings above 70 typically signal an overbought stock, below 30 an oversold one, so this reading sits in neutral territory. Its 50-day moving average is currently above its 200-day moving average, a "golden cross" setup when the shorter average is above (often read as a bullish medium-term signal) or a "death cross" when below (often read as bearish). These are backward-looking statistical measures, not predictions of future price movement.
Who are the major shareholders of Nephrocare Health Services Limited?
As of the latest reported quarter, Nephrocare Health Services Limited's shareholding is split across Promoter (58.31%), Public (41.69%). Promoter holding of 58.31% indicates the founders/controlling group's own stake in the company - a higher promoter holding is often read as a sign of management's confidence in the business, though it should be considered alongside pledge status and recent buying/selling activity, which this figure alone doesn't capture.
Has Nephrocare Health Services Limited seen any recent bulk or block deals?
Yes, as of 2026-09-24 - the most recent recorded deal was a BULK on 2026-09-24 for 8,15,776 shares. Bulk and block deals are large trades (above exchange-defined thresholds) that must be publicly disclosed, and are often watched as a signal of institutional or high-net-worth investor conviction - though a single deal doesn't establish a trend, and the counterparty's reasons for buying or selling aren't disclosed alongside the trade itself.
Stock data · Not financial advice · Past performance does not indicate future returns